SESSION TITLE: Tuesday Fellows Case Report Posters SESSION TYPE: Fellow Case Report Posters PRESENTED ON: 10/22/2019 01:00 PM - 02:00 PM INTRODUCTION: With the extensive immunization campaign, the occurrence of Necrotizing Pneumonia has become less through the years. Early recognition and timely intervention of Pneumonia has contributed to the progressive decline in its incidence. Several factors exist causing reemergence of this uncommon complication. CASE PRESENTATION: This is a case of a 2-year-old female with massive pleural effusion of the left lung, presenting as 3-week productive cough, fever and tachypnea. She had respiratory distress, chest lagging on the left, retractions, decreased fremitus and breath sounds, and dullness with crackles on the left mid to base lung. Chest ultrasound and CT scan showed massive pleural effusion with consolidation on the left lung and atelectasis on the right upper lung. Chest tube drain was exudative, culture, KOH and AFB were negative. Cytology testing was consistent with abscess and negative for malignant cells. Blood culture and PPD skin test were negative. Cefotaxime, Clindamycin, Azithromycin, Vancomycin and Piperacillin- Tazobactam were given, but no response and chest CT scan showed necrosis of the parenchyma. Broncheoalveolar lavage was done revealing heavy growth of Acinetobacter iiwofi and Linezolid and Ciprofloxacin were given with noted clinical improvement and was discharged. DISCUSSION: Necrotizing Pneumonia entails necrosis and liquefaction of consolidated lung tissue. Chest xray has poor sensitivity in cavitary lesion, hence CT scan is the standard of imaging. Risk factors in one study revealed children less than 5 years old, absence of existing medical comorbidity, immature polymorphs in peripheral blood smear, CRP >12 mg/dL, and thrombocytopenia, are associated with pneumonia complications. Prolonged antibiotic treatment has been the cornerstone of therapy in necrotizing pneumonia. The patient was initially given Ceftriaxone and Vancomycin with poor response, due to Vancomycin’s poor parenchymal penetration. Linezolid produced better outcome since it inhibits protein synthesis and toxin production. Surgical approach was considered, but with clinical improvement, medical treatment was continued. Follow up with subsequent chest imaging showed gradual improvement, which confirmed the adequacy of the antibiotic given. CONCLUSIONS: Despite rigorous efforts of the government to provide adequate vaccine coverage, increasing occurrence of necrotizing pneumonia are reported. Increasing awareness among healthcare practitioners for early recognition and timely referral to subspecialist should be emphasized. Necrotizing pneumonia is one of the conditions where medical treatment, over surgical approach, offers the greater advantage. With appropriate antibiotic treatment, the prognosis of necrotizing pneumonia is full recovery. Reference #1: 1. Masters B, Isles A, Grimwood K. Necrotizing pneumonia: an emerging problem in children?. NPJ Open Access [Internet]. 2017 July 25 [cited 2018 Oct 1]; 9:11. Available from: https://pneumonia.biomedcentral.com/articles/10.1186/s41479-017-0035-0 DOI 10.1186/s41479-017-0035-0 Reference #2: 2. Erlichman I, Breuer O, Shoseyov D, Cohen-Cymbreknoh M, Koplewitz B, Aver-buch D, et al. Complicated community acquired pneumonia in childhood: Dif-ferent types, clinical course, and outcome. Pediatric Pulmonology [Internet]. 2017 Feb [cited 2018 Oct 1]; 52:2. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ppul.23523 DOI.org/10.1002/ppul.23523 Reference #3: 3. Treatment Guidelines for the Complicated Pneumonia: Parapneumonic Effu-sions, Empyema, Necrotizing Pneumonia, And Pulmonary abscess. Children’s National Medical Center [Internet]. Washington; 2008 Sept 1 [cited 2018 Oct 1]; 13p. Available from: http://www.nccpeds.com/rotations/wrPICU/Algorithms/ Linked%20complicated%20pneumonia%20guidelines%20final.pdf DISCLOSURES: No relevant relationships by shanta carleen magalit, source=Web Response